CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award SVP, CFO acquired 122,549 shares (grant or award)
- 4 Grant or award PRESIDENT, CHAIRMAN, CEO acquired 612,745 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Other events
- S-3 Offering Registration Statement
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
Page 4 of 19 · 373 filings